Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 23, 2023 - Issue 9
Submit an article Journal homepage
1,471
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study

Jamie P. Dwyera Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, USAView further author information
,
Abiy Agirob US Evidence, US Medical Affairs, AstraZeneca, Wilmington, DE, USACorrespondence[email protected]
View further author information
,
Pooja Desaic US Renal, US Medical Affairs, AstraZeneca, Wilmington, DE, USAView further author information
&
Henry Cremisic US Renal, US Medical Affairs, AstraZeneca, Wilmington, DE, USAView further author information
Pages 1057-1066 | Received 06 Jun 2023, Accepted 12 Jul 2023, Published online: 04 Aug 2023

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Phil McEwan, Marco Hafner, Vivekenand Jha, Ricardo Correa-Rotter, Gil Chernin, Luca De Nicola, Russell Villanueva, David C. Wheeler, Salvatore Barone, Stephen Nolan & Juan Jose Garcia Sanchez. (2023) Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis. Journal of Medical Economics 26:1, pages 1407-1416.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.